# Trial of MSC1936369B in Subjects With Solid Tumors

> **NCT00982865** · PHASE1 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 182 (actual)

## Conditions studied

- Solid Tumors
- Cancer

## Interventions

- **DRUG:** MSC1936369B
- **DRUG:** MSC1936369B
- **DRUG:** MSC1936369B
- **DRUG:** MSC1936369B

## Key facts

- **NCT ID:** NCT00982865
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-31
- **Primary completion:** 2013-03-31
- **Final completion:** 2016-04-30
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2018-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982865, "Trial of MSC1936369B in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00982865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*